Skip to main content

Table 2 List of major tumor suppressive microRNAs in breast cancer

From: Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management

miRNA

Target

Function

Number of samples a

Reference

miR-125b

EPO, EPOR

Inhibits cell proliferation and differentiation

n = 42

[29]

 

ENPEP, CK2-α,CCNJ, MEGF9

Inhibits cell proliferation

n = 25

[30]

 

ERBB2

Inhibits migration and invasion

Cell line study

[31]

miR-205

HMGB3

Suppresses proliferation and invasion

n = 20

[32,33]

miR-17-92

Mekk2

Promotes NK cell antitumoral activity and reduces metastasis

n = 20

[34,35]

miR-206

Cyclin D2, Cx43

Reduces migration, invasion and metastasis

n = 128

[36,37]

miR-200

ZEB1/2, SNAI1/2

Reduces tumor growth, metastasis and EMT

n = 70

[38-40]

miR-146b

NFkB, STAT3

Reduces survival and metastasis

n = 91

[41,42]

miR-126

IGFBP2, MERTK,PITPNC1

Reduces metastasis and angiogenesis

n = 117, n = 295

[43]

 

No specific targets listed

Reduces tumorigenesis and metastasis

Cell line study

[44]

miR-335

SOX4, TNC

Suppresses metastasis and migration

n = 20

[44,45]

miR-31

RhoA

Inhibits several steps of the invasion-metastasis cascade in breast cancer

n = 54

[46]

 

WAVE3, RhoA

Reduces cancer progression and metastasis

Cell line study

[47]

 

WAVE3

Reduces cancer progression and metastasis

n = 19

[48]

  1. Metastasis-suppressive miRs are indicated in bold. aWhen applying more than one reference, we focused on the study with the most relevant number of investigated patient samples. The other studies serve as validation and confirm the results. CCNJ, cyclin J; CK2-α, casein kinase 2-alpha; Cx43, connexin 43; ENPEP, glutamylaminopeptidase or aminopeptidase A; EPO, erythropoietin; EPOR, erythropoietin receptor; ERBB2, Receptor tyrosine-protein kinase erbB-2 (human epidermal growth factor receptor 2); HMGB3, high-mobility group box 3 gene; IGFBP2, insulin-like growth factor-binding protein 2; MEGF9, multiple EGF-like domains 9; Mekk2, mitogen-activated protein kinase kinase kinase 2; MERTK, c-Mer tyrosine kinase; miRNA, microRNA; NFkB, nuclear factor kappa B; NK, natural killer; PITPNC1, phosphatidylinositol transfer protein, cytoplasmic 1; RhoA, Ras homolog gene family; SNAI1/2, snail family zinc finger 1/2; SOX4, SRY-related HMG-box 4; STAT3, signal transducer and activator of transcription 3; TNC, tenascin C; WAVE3, WAS protein family, member 3; ZEB1/2, zinc finger E-box binding homeobox 1/2.